IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.67▼ 0.02% USD/MXN18.59▲ 0.42% USD/CLP994.16▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN3.41▲ 0.17% USD/ARS1,544▼ 0.02% USD/UYU40.59▲ 3.32% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES911.74▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.69— 0.00% USD/TTD6.75— 0.00% EUR/BRL6.25▼ 0.04% BRENT 92.30 ▼ 3.69% WTI 88.09 ▼ 0.53% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.76% GOLD 3,862 ▼ 0.62% SILVER 47.33 ▼ 3.48% SOY 1,226 ▼ 1.41% CORN 444.00 ▼ 0.34% WHEAT 588.50 ▼ 0.80% COFFEE 276.85 ▼ 0.65% SUGAR 18.37 ▼ 0.22% ORANGE JUICE 136.85 ▼ 2.91% COTTON 81.40 ▲ 3.33% COCOA 5,123 ▲ 1.13% BEEF 220.65 ▲ 0.80% CATTLE 339.03 ▲ 1.00% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00% IBOV 172,457.76 ▲ 0.66% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.67 ▼ 0.02% USD/MXN 18.57 ▲ 0.34% USD/CLP 994.16 ▼ 0.13% USD/COP 3,303 — 0.00% USD/PEN 3.41 ▲ 0.12% USD/ARS 1,544 ▼ 0.02% USD/UYU 40.59 ▲ 3.32% USD/PYG 6,196 — 0.00% USD/BOB 11.59 — 0.00% USD/DOP 60.59 — 0.00% USD/CRC 442.74 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.91 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 911.74 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.69 ▲ 2.75% USD/TTD 6.75 ▲ 2.58% EUR/BRL 6.25 ▼ 0.04% BRENT 92.30 ▼ 3.69% WTI 88.09 ▼ 0.53% IRON ORE 161.91 — — COPPER 6.03 ▼ 0.76% GOLD 3,862 ▼ 0.62% SILVER 47.33 ▼ 3.48% SOY 1,226 ▼ 1.41% CORN 444.00 ▼ 0.34% WHEAT 588.50 ▼ 0.80% COFFEE 276.85 ▼ 0.65% SUGAR 18.37 ▼ 0.22% ORANGE JUICE 136.85 ▼ 2.91% COTTON 81.40 ▲ 3.33% COCOA 5,123 ▲ 1.13% BEEF 220.65 ▲ 0.80% CATTLE 339.03 ▲ 1.00% LITHIUM 58.76 ▼ 1.13% PETR4 45.30 — 0.00% VALE3 63.50 — 0.00% ITUB4 42.27 — 0.00% BBDC4 14.52 — 0.00% ABEV3 15.79 — 0.00% BBAS3 15.10 — 0.00% B3SA3 14.89 ▲ 0.88% WEGE3 51.31 ▼ 0.66% PRIO3 63.30 — 0.00% SUZB3 54.77 — 0.00% RENT3 30.07 — 0.00% AZZA3 15.91 — 0.00% CSAN3 3.10 ▲ 8.77% RAIZ4 20.00 — 0.00% PCAR3 2.56 ▲ 7.11% GMAT3 4.25 ▲ 10.68% PSSA3 46.41 ▲ 1.02% CVCB3 0.83 ▼ 1.19% POSI3 3.15 ▼ 6.53% SLCE3 18.28 ▼ 0.44% NATU3 5.13 ▼ 3.75% BRKM5 3.02 — 0.00% RANI3 8.18 — 0.00% CSNA3 3.72 — 0.00%
since 2009
Monday, November 16, 2026

Covid-19 Brazil

Gamma variant accounts for 90% of cases in São Paulo; Butantan begins clinical trials of Butanvac

By · · 2 min read

RIO DE JANEIRO, BRAZIL – There are 19 coronavirus variants circulating in São Paulo and the P.1 (now called Gamma) variant that originated in Manaus, is predominant in the state, accounting for 89.9% of cases, according to the Network of Variant Alerts coordinated by the Butantan Institute, the São Paulo institute reported Wednesday.

Gamma variant accounts for 90% of cases in São Paulo; Butantan begins clinical trials of Butanvac
“Between January and the end of May, 4,812 complete genomes of 834,114 positive cases were sequenced,” the Butantan said in a statement
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

According to the Butantan, the B.1.1.7 (now called Alpha) variant, which originated in the UK, accounts for 4.2% of analyzed cases, while the B1.1.28 variant, which originated in Manaus, had an incidence of 3.5%. Butantan collected the data between January and May 29.

The data were collected from genomic sequencing of a portion of the positive diagnostic tests performed at the Butantan and other laboratories that make up the network coordinated by the institute. “Between January and the end of May, 4,812 complete genomes of 834,114 positive cases were sequenced,” the Butantan said in a statement.

Also on Wednesday, the Butantan launched the website for pre-registration of volunteers interested in taking part in the Butanvac clinical trials, a vaccine against Covid-19 to be fully produced in Brazil, with technology developed in the United States, eliminating the need to import the active pharmaceutical ingredient (API) from abroad.

Clinical trials with the potential vaccine have been authorized by the Brazilian Health Regulatory Agency (ANVISA).

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Exxon gets Guyana approval for a gas project”

Phase 1 trials will involve 418 volunteers over 18 years of age and will initially be conducted by the University of São Paulo School of Medicine’s Clínicas Hospital in Ribeirão Preto, in the interior of the state.

“Other research centers of excellence have already expressed interest and will be announced soon. Phases 2 and 3 should recruit up to 5,000 volunteers,” said in a statement the São Paulo state government, to which the Butantan is linked.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

Living in or visiting São Paulo? See this month's events and our São Paulo city guide with rents, safety and upcoming concerts.

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.